Medicare Rx Price Controls Inevitable If PBMs Do Not Bear Risk – CMS’ Scully
A Medicare prescription drug plan that does not require PBMs to bear risk for the cost of drugs would inevitably result in federal price controls, Centers for Medicare & Medicaid Services Administrator Tom Scully said
You may also be interested in...
Rep. Jo Ann Emerson's (R-Mo.) Medicare drug discount card/catastrophic coverage bill would rely on a "PBA" (pharmacy benefit administrator) rather than a PBM to process the benefit
House Republicans are confident that their Medicare prescription drug benefit proposal will attract at least 90% of the eligible population, Ways & Means/Health Subcommittee Staff Director John McManus said
The slim prospects for enactment of a Medicare outpatient prescription drug benefit have legislators eyeing the $350 bil. House budget set-aside as a source of enhanced provider reimbursements in 2002